Follow

I wonder how many will die before these are available? 😥
RT @EricTopol: The BQ.1.1 variant is resistant to all available monoclonal antibodies, including Evusheld and Bebtelovimab, leaving immunocompromised individuals particularly vulnerable. There are a few new antibodies currently being tested, with some promise
washingtonpost.com/health/2022 @majohnso

🐦🔗: nitter.eu/NChildersMEP/status/

· · mirror-bot · 0 · 0 · 0
Sign in to participate in the conversation
Mastodon

A Mastodon forum for the discussion of European Union matters. Not run by the EU. Powered by PleromaBot, Nitter and PrivacyDev.net.